(Q51549914)

English

Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales.

scientific article published on 18 September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/23000122

Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales. (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/23000122

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Elizabeth Miller

5

object named as

Elizabeth Miller

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/23000122

Pauline A. Waight

2

object named as

Pauline A Waight

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/23000122

4

object named as

Mary P E Slack

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/23000122

Nick J. Andrews

1

object named as

Nick J Andrews

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/23000122

author name string

Robert C George

3

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/23000122

language of work or name

0 references

publication date

18 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/23000122

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/23000122

30

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/23000122

48

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/23000122

6802-6808

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/23000122

The current burden of pneumococcal disease in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.019

7 January 2021

Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.019

7 January 2021

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.019

7 January 2021

The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.019

7 January 2021

The 23-Valent Pneumococcal Polysaccharide Vaccine. Part II. A Cost-Effectiveness Analysis for Invasive Disease in the Elderly in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.019

7 January 2021

Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.019

7 January 2021

The effect of polyvalent pneumococcal polysaccharide vaccine on nasopharyngeal and nasal carriage of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.019

7 January 2021

Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.019

7 January 2021

Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996–2006

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.019

7 January 2021

Effects of a large-scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.019

7 January 2021

Effectiveness of a publicly funded pneumococcal vaccination program against invasive pneumococcal disease among the elderly in Victoria, Australia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.019

7 January 2021

The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.019

7 January 2021

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.019

7 January 2021

Effectiveness of pneumococcal polysaccharide vaccine in older adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.019

7 January 2021

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.019

7 January 2021

Pneumococcal Vaccination and Revaccination of Older Adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.019

7 January 2021

Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.019

7 January 2021

The Immunogenicity of 7‐Valent Pneumococcal Conjugate Vaccine versus 23‐Valent Polysaccharide Vaccine in Adults Aged 50–80 Years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.019

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.09.019

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/23000122

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/23000122

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51549914&oldid=1907884130"